(주)하이센스바이오

{
  "address": "경기 과천시",
  "ceo_name": "박주철, 이석현",
  "certificate": [
    {
      "cert_number": "20160109563",
      "changes": "",
      "disclosure_date": "2016-08-18",
      "first_cert_date": "2016-08-18",
      "no": "1",
      "type": "기술평가보증기업(기금)",
      "valid_period": "2016-08-18 ~ 2018-08-17"
    },
    {
      "cert_number": "20180300593",
      "changes": "",
      "disclosure_date": "2018-08-23",
      "first_cert_date": "2016-08-18",
      "no": "2",
      "type": "벤처투자유형",
      "valid_period": "2018-08-18 ~ 2020-08-17"
    },
    {
      "cert_number": "20200300874",
      "changes": "",
      "disclosure_date": "2020-07-30",
      "first_cert_date": "2016-08-18",
      "no": "3",
      "type": "벤처투자유형",
      "valid_period": "2020-08-18 ~ 2022-08-17"
    },
    {
      "cert_number": "20220907010003",
      "changes": "",
      "disclosure_date": "2022-09-07",
      "first_cert_date": "2016-08-18",
      "no": "4",
      "type": "벤처투자유형",
      "valid_period": "2022-08-18 ~ 2025-08-17"
    },
    {
      "cert_number": "20250722010019",
      "changes": "",
      "disclosure_date": "2025-07-22",
      "first_cert_date": "2016-08-18",
      "no": "5",
      "type": "벤처투자유형",
      "valid_period": "2025-08-18 ~ 2028-08-17"
    }
  ],
  "company_name": "(주)하이센스바이오",
  "corp_no": "110111-*******",
  "financials": {
    "2022": {
      "capital_stock": 3806788000,
      "cost_of_sales": 0,
      "current_assets": 7627264000,
      "current_liabilities": 711565000,
      "gross_profit": 5958554000,
      "net_income": -3522337000,
      "net_income_bs": -3522338000,
      "non_current_assets": 6058480000,
      "non_current_liabilities": 35664000,
      "non_operating_expenses": 3516190000,
      "non_operating_income": 103265000,
      "operating_profit": -109412000,
      "revenue": 5958554000,
      "sga_expenses": 6067966000,
      "total_assets": 13685744000,
      "total_equity": 12938514000,
      "total_liabilities": 747230000
    },
    "2023": {
      "capital_stock": 4344691000,
      "cost_of_sales": 0,
      "current_assets": 15061043000,
      "current_liabilities": 1138474000,
      "gross_profit": 625478000,
      "net_income": -7529168000,
      "net_income_bs": -7529167000,
      "non_current_assets": 6225341000,
      "non_current_liabilities": 2554834000,
      "non_operating_expenses": 1104705000,
      "non_operating_income": 713373000,
      "operating_profit": -7137836000,
      "revenue": 625478000,
      "sga_expenses": 7763314000,
      "total_assets": 21286383000,
      "total_equity": 17593075000,
      "total_liabilities": 3693308000
    },
    "2024": {
      "capital_stock": 4384191000,
      "cost_of_sales": 9199000,
      "current_assets": 8233992000,
      "current_liabilities": 1169724000,
      "gross_profit": 71746000,
      "net_income": -8684981000,
      "net_income_bs": -8684982000,
      "non_current_assets": 5996220000,
      "non_current_liabilities": 2478213000,
      "non_operating_expenses": 145340000,
      "non_operating_income": 461076000,
      "operating_profit": -9000717000,
      "revenue": 80945000,
      "sga_expenses": 9072463000,
      "total_assets": 14230213000,
      "total_equity": 10582275000,
      "total_liabilities": 3647937000
    }
  },
  "industry": "의학 및 약학 연구개발업",
  "investment": [
    {
      "amount": "1,339,993,600",
      "changes": "1,339,993,600",
      "date": "2023-06-27"
    },
    {
      "amount": "4,499,000,000",
      "changes": "4,499,000,000",
      "date": "2021-04-20"
    },
    {
      "amount": "1,666,000,000",
      "changes": "1,666,000,000",
      "date": "2021-04-16"
    },
    {
      "amount": "1,743,000,000",
      "changes": "1,743,000,000",
      "date": "2021-04-15"
    },
    {
      "amount": "1,998,000,000",
      "changes": "1,998,000,000",
      "date": "2019-05-24"
    },
    {
      "amount": "4,999,925,000",
      "changes": "4,999,925,000",
      "date": "2019-05-17"
    },
    {
      "amount": "4,999,000,000",
      "changes": "4,999,000,000",
      "date": "2019-05-17"
    }
  ],
  "main_products": "의약품 연구개발",
  "phone": "02-883-****",
  "years": [
    2024,
    2023,
    2022
  ]
}